George L Sing Net Worth & Insider Trades

George L Sing - Director, Regeneron Pharmaceuticals, Inc

As of March 1, 2022

What is George L Sing's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's Director, George L Sing, is estimated to be about $212.15M . George L Sing owns about 27,049 units of Regeneron Pharmaceuticals, Inc common stock. In the last 18 years at Regeneron Pharmaceuticals, Inc, George L Sing has sold an estimated value of $141.71M worth.

What is George L Sing's Past Insider Trading?

George L Sing's largest purchase order was 30,000 units , worth over $3.52M on August 24, 2020. George L Sing's largest sale order was 61,000 units , worth over $36.93M on August 24, 2020. In total, George L Sing has made about 55 transactions over 18 years of their time at Regeneron Pharmaceuticals, Inc. George L Sing usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 4,000 units , worth over $2.47M on March 1, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was George L Sing's Salary in 2020?

As Director of Regeneron Pharmaceuticals, Inc, George L Sing has a total base salary of $1,258,096 . George L Sing received compensation valued at about $134,383,319 in 2020 after becoming Director. The vast majority of their compensation came in the form of stock awards of $130,000,032 , other earnings, plans or compensations of $3,004,391 , other earnings, plans or compensations of $3,004,391 , and other compensation of $120,800 .

What is George L Sing's' Mailing Address?

  • Mailing address is Lancet Capital 45 Rockefeller Plaza Ste 2008 New York NY 10111 NY

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on September 13, 2022 by Daniel P. van Plew who sold 40,000 units worth $29.17M . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.39B and bought an estimated value of $3.47B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1